stars 1 stars 2 stars 3

Since 1981, ChM has been designing, manufacturing and distributing comprehensive system solutions for traumatology and orthopaedics, developed in cooperation with medical professionals around the world. The company’s portfolio includes standard osteosynthesis solutions, such as intramedullary nailing systems (CHARFIX, CHARFIX2, ChFN2) and the ChLP locking plate system, as well as specialised products, including the KPS bipolar radial head prosthesis and the FN fusion nail. ChM also develops dedicated solutions for spine and thoracic surgery, including the CHARSPINE2 thoracolumbar spinal stabilisation system and the sterno-costal plate system, designed for the treatment of injuries and other conditions affecting the spine and thorax. ChM implants and instruments are developed to support effective treatment while enhancing the comfort and efficiency of surgeons and operating room personnel. Our uncompromising commitment to quality is confirmed by ISO certificates, annually validated by the internationally recognised notified body TÜV, as well as CE marking.

CHM Implants & Instruments Questions

The CHM Implants & Instruments annual revenue was $25.9 million in 2026.

Roman Łukasiński is the Prezes zarządu of CHM Implants & Instruments.

69 people are employed at CHM Implants & Instruments.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users